Significant Benefits In Non-small-cell Lung Cancer From Customizing Erlotinib Treatment

Monday, September 15, 2008 - 13:35 in Health & Medicine

Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, researchers report.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net